As invasive medical devices, AVF needles' surface finish directly correlates with infection risk and clinical safety. Manufacturers rely on two core processes - electropolishing and ultrasonic cleaning - to eliminate contaminants and optimize surface properties at the microscopic level, forming physical barriers against bacterial colonization.

Electropolishing: From Micro Roughness to Near-Atomically Smooth Surfaces

Conventional mechanical polishing leaves micro-scratches and metallic debris that serve as breeding grounds for bacterial adhesion. In electropolishing, needles are mounted as anodes immersed in electrolyte; direct current dissolves surface metallic ions to strip off a 0.5–2 μm-thick surface layer. This procedure eliminates machining marks and burrs, cutting arithmetic mean roughness (Ra) from 1.6 μm down to below 0.1 μm to produce a mirror-smooth finish.

Manners Technology uses a phosphoric-sulfuric acid blended electrolyte system. By regulating current density (10–30 A/dm²) and bath temperature (50–70 °C), the firm achieves uniform polishing across needle tips and shafts. The process raises surface chromium-to-iron ratio from 1:1 to 1.5:1 and strengthens the corrosion-resistant passive oxide film.

Ultrasonic Cleaning: Dead-Zone-Free Purification for Inner Lumens and Laser Grooves

Inner bores and laser-etched grooves of AVF needles are prone to trapped contaminants. Manufacturers deploy 40 kHz high-frequency ultrasonic cleaning, where cavitation-induced micro-shockwaves strip grease and particulate residues. The standardized four-stage cleaning sequence is specified below:

• Pre-rinse: Flush with deionized water to remove loose surface dust;
• Alkaline wash: Surfactant-containing solution (pH 10–12) emulsifies residual cutting oil;
• Acid rinse: Dilute nitric acid neutralizes leftover alkaline residues and removes free metal ions;
• Final rinse: Ultra-pure water (resistivity ≥18 MΩ·cm) flushes out all chemical contaminants.

To validate cleanliness, manufacturers perform particulate counting: each needle shall carry no more than 100 particles ≥0.5 μm in size, with zero soluble protein residues quantified via the BCA assay at ≤0.1 μg/cm².

Final Closed-Loop Control via Cleanroom Packaging

Fully cleaned AVF needles are packaged within ISO Class 7 cleanrooms using co-extruded dual-layer pouches: gas-permeable dialysis paper as the inner layer and aluminum foil laminate as the outer layer, heat-sealed to maintain intact sterile barriers. Each package bears a Unique Device Identification (UDI) encoding production lot number, sterilization date and expiry date for full lifecycle traceability. Manners Technology also offers customized packaging with pre-attached accessories such as tourniquets and adhesive dressings to streamline clinical usage.

Clinical Benefits of Surface Modification

Clinical studies prove electropolishing reduces bacterial adhesion on AVF needle surfaces by 60% and lowers thrombogenesis risk by 45%. Smooth surfaces suppress platelet activation and extend the service life of hemodialysis access routes. Manufacturers conduct periodic surface energy tests (contact angle ≤70°) and protein adsorption assays to sustain consistent surface treatment performance.

Conclusion

Surface engineering constitutes the frontline of microbial prevention for AVF needles, requiring manufacturers to translate microscopic cleanliness into quantifiable quality specifications. Rigorous surface finishing alongside controlled cleanroom packaging is essential to delivering safe hemodialysis devices for patients.